There is no business for Novo Nordisk in that area. Focus on obesity from the beginning (this is actually from ACQ2, a second podcast hosted by Gilbert and Rosenthal, in an episode focused on Knudsen): The target market was also obesity from the beginning, Knudsen says about GLP-1 molecules, pushing back on idea that they somehow stumbled into obesity
Even with insurance, copays can be steep, and many plans do not cover weight loss indications at all
while respiratory viral infections cause antioxidant enzyme expression/activity inhibition associated with reduced Nrf2 nuclear localization, decreased cellular levels and reduced ARE-dependent gene transcription (Komaravelli and Casola, 2014)
This is especially true if your symptoms dont go away or actually get worse
Heres why: Rare skin cancers may be mistaken for noncancerous conditions, delaying diagnosis and treatment
Many users experience nausea, vomiting, diarrhea, and abdominal pain, especially when starting the treatment